Compare ELF & TFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ELF | TFX |
|---|---|---|
| Founded | 2004 | 1943 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Package Goods/Cosmetics | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8B | 5.4B |
| IPO Year | 2016 | N/A |
| Metric | ELF | TFX |
|---|---|---|
| Price | $93.64 | $106.19 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 17 | 10 |
| Target Price | $125.00 | ★ $139.88 |
| AVG Volume (30 Days) | ★ 1.6M | 843.0K |
| Earning Date | 02-04-2026 | 02-26-2026 |
| Dividend Yield | N/A | ★ 1.36% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.40 | N/A |
| Revenue | $1,385,640,000.00 | ★ $3,189,988,000.00 |
| Revenue This Year | $20.59 | $9.70 |
| Revenue Next Year | $16.73 | $10.35 |
| P/E Ratio | $65.67 | ★ N/A |
| Revenue Growth | ★ 13.80 | 5.42 |
| 52 Week Low | $49.40 | $100.18 |
| 52 Week High | $150.99 | $185.94 |
| Indicator | ELF | TFX |
|---|---|---|
| Relative Strength Index (RSI) | 69.36 | 39.59 |
| Support Level | $87.00 | $100.18 |
| Resistance Level | $88.20 | $106.53 |
| Average True Range (ATR) | 3.97 | 3.62 |
| MACD | 1.40 | -1.41 |
| Stochastic Oscillator | 96.16 | 22.57 |
e.l.f. Beauty Inc is a multi-brand beauty company that offers inclusive, accessible, clean, vegan, and cruelty-free cosmetics and skin care products. The Company's mission is to make beauty accessible to every eye, lip, face, and skin concern. The company offers cosmetic accessories for women, which include eyeliner, mascara, false eyelashes, lipstick, foundation for the face, moisturizer, cleanser, and other tools through its stores and e-commerce channels.
Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2024 sales), interventional (19%), anesthesia (13%), surgical (15%), interventional urology (11%), original-equipment manufacturing (11%), and other (7%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.